Invention Grant
- Patent Title: Method for detecting mycoplasma using mitochondrial DNA as internal control sample
-
Application No.: US17055551Application Date: 2019-05-17
-
Publication No.: US11434527B2Publication Date: 2022-09-06
- Inventor: Eun Ju Kang , Yeon Mi Lee
- Applicant: The Asan Foundation , University of Ulsan Foundation for Industry Cooperation
- Applicant Address: KR Seoul; KR Ulsan
- Assignee: The Asan Foundation,University of Ulsan Foundation for Industry Cooperation
- Current Assignee: The Asan Foundation,University of Ulsan Foundation for Industry Cooperation
- Current Assignee Address: KR Seoul; KR Ulsan
- Agency: Morrison & Foerster LLP
- Priority: KR10-2018-0057283 20180518
- International Application: PCT/KR2019/005898 WO 20190517
- International Announcement: WO2019/221537 WO 20191121
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6851 ; C12Q1/6888

Abstract:
The present invention provides a method for detecting mycoplasma, which can directly confirm whether a cell is infected with mycoplasma, by simultaneously amplifying DNA extracted from lysing a host cell infected with mycoplasma, and mitochondrial DNA in the cytoplasm of the host cell. According to the method of the present invention, by directly using the DNA inside the host cell, the DNA of mycoplasma bound around the nucleus of the host cell can be used as an amplification target, thereby increasing detection sensitivity. In addition, since the mitochondrial DNA inside the host cell is used as an amplification target of an internal control sample, whether the sample has been sampled in an appropriate amount can be confirmed in a convenient manner, and furthermore, by comparing the band size between the internal control sample and the mycoplasma DNA, the degree of mycoplasma infection can be quantitatively confirmed.
Public/Granted literature
- US20210115505A1 METHOD FOR DETECTING MYCOPLASMA USING MITOCHONDRIAL DNA AS INTERNAL CONTROL SAMPLE Public/Granted day:2021-04-22
Information query